Aldose reductase is a tiny, cytosolic, monomeric enzyme that is a member of the aldo-keto reductase superfamily. Numerous aromatic and aliphatic carbonyl compounds are reduced by aldose reductase using the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH). It has been linked to the emergence of diabetic and galactosemic complications that affect the kidney, nerves, lens, and retina.
Aldose reductase is a crucial polyol pathway enzyme that, when activated under hyperglycemic conditions, causes the development of chronic diabetic complications. It is also a key factor in the promotion of inflammatory and cytotoxic conditions, even when blood sugar levels are normal. Aldose reductase is a fantastic drug target, and there is a lot of work being done to identify new substances that can inhibit it.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V87286 | 5-Bromo-3-phenyl salicylic acid | 99514-99-5 | 5-Bromo-3-phenyl salicylic acid is a selective inhibitor of human 20α-hydroxysteroid dehydrogenase (AKR1C1) with Ki value of 140 nM. | |
V73734 | 6,7-Dihydroxy-4-coumarinylacetic acid | 88404-14-2 | 6,7-Dihydroxy-4-coumarinylacetic acid is a potent and specific inhibitor of ALR2. | |
V73729 | 6-Hydroxyluteolin | 18003-33-3 | 6-Hydroxyluteolin (Compound 17) is a flavonoid compound. | |
V73733 | AKR1B10-IN-1 | 2136579-33-2 | AKR1B10-IN-1 is a potent inhibitor of AKR1B10 with IC50 of 3.5 nM. | |
V87281 | AKR1C2/3-IN-1 | AKR1C2/3-IN-1 (compound 3a) is a potent AKR1C2 and AKR1C3 inhibitor with IC50 values of 90 and 50 nM, respectively. | ||
V77870 | AKR1C3-IN-10 | 3028287-43-3 | AKR1C3-IN-10 (compound 5r) is a selective AKR1C3 inhibitor (IC50=51 nM). | |
V83455 | AKR1C3-IN-11 | |||
V87284 | AKR1C3-IN-12 | 891075-67-5 | AKR1C3-IN-12 (compound 2j) is an aldehyde-keto reductase 1C3 (AKR1C3) inhibitor with IC50 of 27 nM. | |
V87283 | AKR1C3-IN-14 | 1057882-82-2 | AKR1C3-IN-14 (compound 4) is an AKR1C3 inhibitor (IC50=0.122 μM) that reduces the overproduction of androgens by inhibiting the activity of the AKR1C3 enzyme, thereby regulating hormone-mediated signaling. | |
V73732 | AKR1C3-IN-9 | 2924824-43-9 | AKR1C3-IN-9 is a selective inhibitor of aldehyde-keto reductase 1C3 (AKR1C3) with IC50 of 8.92 nM. | |
V87285 | Aldose reductase-IN-7 | Aldose reductase-IN-7 (Compound 6k) targets Aldose reductase and exhibits potent enzyme inhibitory activity (Ki = 0.186 ± 0.020 μM), which is superior to Epalrestat. | ||
V73731 | ALR2-IN-1 | 2799695-54-6 | ALR2-IN-1 is a potent and specific inhibitor of ALR2 (IC50=1.42 μM). | |
V80090 | ALR2-IN-2 | ALR2-IN-2 is a potent aldose reductase (ALR2) inhibitor, with IC50s of 27 nM and 228 nM for rat ALR2 and ALR1 inhibition, respectively. | ||
V80087 | ALR2-IN-3 | ALR2-IN-2 is a potent aldose reductase (ALR2) inhibitor, with IC50s of 22 nM and 116 nM for rat ALR2 and ALR1 inhibition, respectively. | ||
V37639 | AT-007 | 2170729-29-8 | AT-007 is a novel and orally bioactive central nervous system (CNS) penetrant Aldose Reductase inhibitor for treatment of Galactosemia with an IC50 value of 100 pM. | |
V87278 | Floramanoside A | 1487423-38-0 | Floramanoside A is a flavonol glycoside isolated from the flowers of Abelmouschus manihot. | |
V86299 | Floramanoside C | 1403981-95-2 | ||
V87280 | Floramanoside D | 1487423-55-1 | Floramanoside D is a flavonol glycoside. | |
V73730 | Ganoderic acid C6 | 105742-76-5 | Ganoderic acid C6 has aldose reductase inhibitory activity. | |
V73735 | Ganoderic acid Df | 1352033-73-8 | Ganoderic acid Df is a lanosterane-type triterpenoid compound that can be extracted from the fruiting bodies of Ganoderma lucidum. |